Logo

Experimental peptide treatment could triple survival rates in severe blood loss cases

Experimental peptide treatment could triple survival rates in severe blood loss cases

Researchers at the Hebrew University of Jerusalem and the IDF Medical Corps have discovered a promising new therapeutic approach to treating hemorrhagic shock, a life-threatening condition caused by severe blood loss that remains the leading cause of preventable death in trauma cases globally.

👉 Full Story